scispace - formally typeset
E

E. I. Zhabitskaya

Researcher at Joint Institute for Nuclear Research

Publications -  13
Citations -  131

E. I. Zhabitskaya is an academic researcher from Joint Institute for Nuclear Research. The author has contributed to research in topics: Phospholipid transport & Population. The author has an hindex of 6, co-authored 12 publications receiving 114 citations. Previous affiliations of E. I. Zhabitskaya include International University, Cambodia.

Papers
More filters
Book ChapterDOI

Asynchronous differential evolution

TL;DR: A novel Asynchronous Differential Evolution (ADE) is well suited for parallel optimization and even in the sequential mode its rate of convergence is competitive to CDE.
Proceedings ArticleDOI

Asynchronous differential evolution with adaptive correlation matrix

TL;DR: This paper incorporates crossover based on adaptive correlation matrix into Asynchronous differential evolution (ADE), and thanks to the proposed crossover the novel algorithm automatically adapts to the landscape of the optimized objective function.
Book ChapterDOI

Asynchronous Differential Evolution with Restart

TL;DR: This work derives ADE with restart ADE-R from ADE by increasing population size after each restart, new strategy enhances its chances to locate the global minimum.
Journal ArticleDOI

Investigation of the structure of unilamellar dimyristoylphosphatidylcholine vesicles in aqueous sucrose solutions by small-angle neutron and X-ray scattering

TL;DR: In this article, the structure of a polydispersed population of unilamellar dimyristoylphosphatidylcholine (DMPC) vesicles in sucrose solutions has been investigated by small-angle neutron scattering (SANS) and smallangle X-ray scattering (SAXS).
Journal ArticleDOI

Application of small-angle X-ray scattering to the characterization and quantification of the drug transport nanosystem based on the soybean phosphatidylcholine.

TL;DR: It is demonstrated that PTNS is a vesicular system with an average vesicle radius of 160 ± 2Å and the key question from the viewpoint of organization of drug incorporation whether the PTNS nanoparticles have a structure of micelles or vesicles is answered.